|
Originally published In Press as doi:10.1074/jbc.M107337200 on October 23, 2001
J. Biol. Chem., Vol. 276, Issue 52, 49251-49257, December 28, 2001
Biochemical Defects in 11-cis-Retinol
Dehydrogenase Mutants Associated with Fundus Albipunctatus*
Martin
Lidén §,
Anna
Romert §,
Kristian
Tryggvason ,
Bengt
Persson¶, and
Ulf
Eriksson
From the Ludwig Institute for Cancer Research,
Stockholm Branch, Box 240 and ¶ Department of Medical Biochemistry
and Biophysics and Stockholm Bioinformatics Center, Karolinska
Institutet, S-171 77 Stockholm, Sweden
Mutations in the gene encoding
11-cis-retinol dehydrogenase (RDH5; EC 1.1.1.105) are
associated with fundus albipunctatus, an autosomal recessive eye
disease characterized by stationary night blindness and accumulation of
white spots in the retina. In addition, some mutated alleles are
associated with development of cone dystrophy, especially in elderly
patients. The numbers of identified RDH5 mutations linked to fundus
albipunctatus have increased considerably during recent years. In this
work, we have characterized the biochemical and cell biological
properties of 11 mutants of RDH5 to understand the molecular pathology
of the disease. All RDH5 mutants showed decreased protein stability and subcellular mislocalization and, in most cases, loss of enzymatic activity in vitro and in vivo. Surprisingly,
mutant A294P displays significant enzymatic activity. Cross-linking
studies and molecular modeling showed that RDH5 is dimeric, and
co-expression analyses of wild-type and mutated alleles showed that the
mutated enzymes, in a trans-dominant-negative manner, influenced the
in vivo enzymatic properties of functional variants of the
enzyme, particularly the A294P mutant. Thus, under certain conditions,
nonfunctional alleles act in a dominant-negative way on functional but
relatively unstable mutated alleles. However, in heterozygous
individuals carrying one wild-type allele, the disease is recessive,
probably due to the stability of the wild-type enzyme.
*
This work was supported by the Swedish Medical Research
Council (K99-03P-12070-03C), the Karolinska Institiutet, the European Commission (Bio4-CT97-2123), the Swedish Foundation for Strategic Research, and the Åke Wiberg Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Both authors contributed equally to this work.
To whom correspondence should be addressed. Tel.:
46-8-728-7109; Fax: 46-8-332812; E-mail: ueri@licr.ki.se.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Liden and U. Eriksson
Understanding Retinol Metabolism: Structure and Function of Retinol Dehydrogenases
J. Biol. Chem.,
May 12, 2006;
281(19):
13001 - 13004.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Thompson, A. R. Janecke, J. Lange, K. L. Feathers, C. A. Hubner, C. L. McHenry, D. W. Stockton, G. Rammesmayer, J. R. Lupski, G. Antinolo, et al.
Retinal degeneration associated with RDH12 mutations results from decreased 11-cis retinal synthesis due to disruption of the visual cycle
Hum. Mol. Genet.,
December 15, 2005;
14(24):
3865 - 3875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Strauss
The Retinal Pigment Epithelium in Visual Function
Physiol Rev,
July 1, 2005;
85(3):
845 - 881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Niwa, M. Kondo, S. Ueno, M. Nakamura, H. Terasaki, and Y. Miyake
Cone and Rod Dysfunction in Fundus Albipunctatus with RDH5 Mutation: An Electrophysiological Study
Invest. Ophthalmol. Vis. Sci.,
April 1, 2005;
46(4):
1480 - 1485.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|